Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2041)
All Articles published online
|
Aug 1, 2004 (publication date) through Apr 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Okuda K, Yokosuka O. Natural history of chronic hepatitis C in patients on hemodialysis: Case control study with 4-23 years of follow-up. World J Gastroenterol 2004; 10(15): 2209-2212 [PMID: 15259067 DOI: 10.3748/wjg.v10.i15.2209] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i15/2209.htm |
| Number | Citing Articles |
| 1 |
Smaragdi Marinaki, John N Boletis, Stratigoula Sakellariou, Ioanna K Delladetsima. Hepatitis C in hemodialysis patients. World Journal of Hepatology 2015; 7(3): 548-558 doi: 10.4254/wjh.v7.i3.548
|
| 2 |
Satawat Thongsawat, Niwat Maneekarn, Mark H. Kuniholm, Chansom Pantip, Amornrat Thungsuputi, Dusit Lumlertkul, Derek Bannachak, Kenrad E. Nelson. Occult hepatitis C virus infection during an outbreak in a hemodialysis unit in Thailand. Journal of Medical Virology 2008; 80(5): 808 doi: 10.1002/jmv.21126
|
| 3 |
Roberta Angelico, Giuseppe Iaria, Mario Angelico. Kidney Transplantation, Bioengineering and Regeneration. 2017; : 653 doi: 10.1016/B978-0-12-801734-0.00046-1
|
| 4 |
Ronaldo Soares Martins, Olindo Assis Martins Filho, Neiva Sellan Lopes Gonçales, Dora Méndez del Castillo, Luciana Diniz Silva, Luciana Costa Faria, Rosangela Teixeira. Kinetics of hepatitis C virus load and hemodialysis: Is there any influence of the reuse of dialysis membrane on HCV viremia?. Scandinavian Journal of Infectious Diseases 2012; 44(3): 190 doi: 10.3109/00365548.2011.627377
|
| 5 |
Toshikazu Araoka, Hiroya Takeoka, Keisuke Nishioka, Seiji Kishi, Makoto Araki, Fumi Kishi, Reiko Shigeta, Taichi Murakami, Naoki Kondo, Motokazu Matsuura, Kazuhiro Yoshikawa, Akira Mima, Kojiro Nagai, Toshikazu Takahashi, Hideharu Abe, Masaki Ikeda, Makiko Kondo, Azusa Sugiyama, Masahiko Sugano, Toshio Doi. Safety and efficacy of interferon-beta therapy for hemodialysis patient with HCV. Nihon Toseki Igakkai Zasshi 2009; 42(5): 393 doi: 10.4009/jsdt.42.393
|
| 6 |
Roberto J Carvalho-Filho, Ana Cristina CA Feldner, Antonio Eduardo B Silva, Maria Lucia G Ferraz. Management of hepatitis C in patients with chronic kidney disease. World Journal of Gastroenterology 2015; 21(2): 408-422 doi: 10.3748/wjg.v21.i2.408
|
| 7 |
Claudia Cottone, Kalyan Ram Bhamidimarri. Evaluating CKD/ESRD patient with hepatitis C infection: How to interpret diagnostic testing and assess liver injury. Seminars in Dialysis 2019; 32(2): 119 doi: 10.1111/sdi.12760
|
| 8 |
Ruzica Lukic, Nevena Gajovic, Ivan Jovanovic, Milena Jurisevic, Zeljko Mijailovic, Veljko Maric, Biljana Popovska Jovicic, Nebojsa Arsenijevic. Potential Hepatoprotective Role of Galectin-3 during HCV Infection in End-Stage Renal Disease Patients. Disease Markers 2017; 2017: 1 doi: 10.1155/2017/6275987
|
| 9 |
Pavlina Dzekova-Vidimliski, Aleksandar Sikole. Hepatitis C Virus Infection in Maintenance Hemodialysis Patients: Recommendations for Diagnostics and Treatment. The International Journal of Artificial Organs 2016; 39(12): 590 doi: 10.5301/ijao.5000548
|
| 10 |
Jennifer T. Wells, Michael R. Lucey, Adnan Said. Hepatitis C in Transplant Recipients of Solid Organs, Other than Liver. Clinics in Liver Disease 2006; 10(4): 901 doi: 10.1016/j.cld.2006.08.025
|
| 11 |
F. Fabrizi, B. Takkouche, G. Lunghi, V. Dixit, P. Messa, P. Martin. The impact of hepatitis C virus infection on survival in dialysis patients: meta‐analysis of observational studies. Journal of Viral Hepatitis 2007; 14(10): 697 doi: 10.1111/j.1365-2893.2007.00868.x
|
| 12 |
|
| 13 |
Tetsuro Sekiguchi, Takeaki Nagamine, Hitoshi Takagi, Masatomo Mori. Reduction of virus burden-induced splenectomy in patients with liver cirrhosis related to hepatitis C virus infection. World Journal of Gastroenterology 2006; 12(13): 2089-2094 doi: 10.3748/wjg.v12.i13.2089
|
| 14 |
Mohamed Eida. Chronic hepatitis C genotype 4 treatment in chronic haemodialysis patients: A retrospective study. Arab Journal of Gastroenterology 2010; 11(2): 83 doi: 10.1016/j.ajg.2010.04.004
|
| 15 |
Ravindra A Prabhu, Sreekumar Nair, Ganesh Pai, Nageswara P Reddy, Deepak Suvarna. Interventions for dialysis patients with hepatitis C virus (HCV) infection. Cochrane Database of Systematic Reviews 2015; 2015(8) doi: 10.1002/14651858.CD007003.pub2
|
| 16 |
Fabrizio Fabrizi, Vivek Dixit, Piergiorgio Messa. Hepatitis C virus and mortality among patients on dialysis: A systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2019; 43(3): 244 doi: 10.1016/j.clinre.2018.10.009
|
| 17 |
APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment?. Hepatology International 2019; 13(2): 103 doi: 10.1007/s12072-018-9915-5
|
| 18 |
Charles S. Whang, Ke-Qin Hu. Hepatitis C in patients with chronic kidney disease: Course and management. Current Hepatitis Reports 2007; 6(3): 96 doi: 10.1007/s11901-007-0011-x
|
| 19 |
Takashi Akiba, Kazuhiko Hora, Michio Imawari, Chifumi Sato, Eiji Tanaka, Namiki Izumi, Takashi Harada, Ryoichi Ando, Kan Kikuchi, Tadashi Tomo, Hideki Hirakata, Tadao Akizawa. 2011 Japanese Society for Dialysis Therapy Guidelines for the Treatment of Hepatitis C Virus Infection in Dialysis Patients. Therapeutic Apheresis and Dialysis 2012; 16(4): 289 doi: 10.1111/j.1744-9987.2012.01078.x
|
| 20 |
Lionel Rostaing, Laurent Alric, Jacques Izopet, Nassim Kamar. What are the Management Issues for Hepatitis C in Dialysis Patients?. Seminars in Dialysis 2014; 27(5): 451 doi: 10.1111/sdi.12290
|
| 21 |
Vinod K. Rustgi. The epidemiology of hepatitis C infection in the United States. Journal of Gastroenterology 2007; 42(7): 513 doi: 10.1007/s00535-007-2064-6
|
| 22 |
Chen-Hua Liu, Yu-Jen Fang, Chun-Jen Liu, Tung-Hung Su, Shang-Chin Huang, Tai-Chung Tseng, Jo-Hsuan Wu, Pei-Jer Chen, Jia-Horng Kao. Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection. Journal of Clinical Medicine 2023; 12(5): 2020 doi: 10.3390/jcm12052020
|
| 23 |
Renata Eliane de Ávila, Ricardo Andrade Carmo, Kátia de Paula Farah, Antônio Lúcio Teixeira, Lucas Viana Coimbra, Carlos Maurício de Figueiredo Antunes, José Roberto Lambertucci. Hyaluronic acid in the evaluation of liver fibrosis in patients with hepatitis C on haemodialysis. The Brazilian Journal of Infectious Diseases 2010; 14(4): 335 doi: 10.1016/S1413-8670(10)70071-4
|
| 24 |
Kátia V. B. D. Barbosa, Rosângela Teixeira, Eric Bassetti‐Soares, Aécio F. Meirelles de Souza, João Milton M. O. Penido, Andréa Teixeira‐Carvalho, Olindo A. Martins‐Filho. Phenotypic features of innate and adaptive immunity in patients with chronic hepatitis C and end‐stage renal disease. Liver International 2013; 33(9): 1349 doi: 10.1111/liv.12204
|
| 25 |
F. Fabrizi, P. Messa, P. Martin. Impact of Hemodialysis Therapy on Hepatitis C Virus Infection: A Deeper Insight. The International Journal of Artificial Organs 2009; 32(1): 1 doi: 10.1177/039139880903200101
|
| 26 |
Fabrizio Fabrizi, Piergiorgio Messa, Carlo Basile, Paul Martin. Hepatic disorders in chronic kidney disease. Nature Reviews Nephrology 2010; 6(7): 395 doi: 10.1038/nrneph.2010.37
|
| 27 |
Hongdi Cao, Ping Wen, Hong Ye, Zhiping Sun, Xia Shen, Xiaochun Wu, Chunsun Dai, Junwei Yang, Ranjit Ray. A Study of the Immunoloregulation of Double Filtration Plasmapheresis in Maintenance Hemodialysis Patients with Chronic Hepatitis C. PLoS ONE 2013; 8(12): e82524 doi: 10.1371/journal.pone.0082524
|
| 28 |
Maria Rendina, Antonio Schena, Nicola Maurizio Castellaneta, Francesco Losito, Anna Cinzia Amoruso, Giovanni Stallone, Francesco Paolo Schena, Alfredo Di Leo, Antonio Francavilla. The treatment of chronic hepatitis C with peginterferon alfa-2a (40kDa) plus ribavirin in haemodialysed patients awaiting renal transplant. Journal of Hepatology 2007; 46(5): 768 doi: 10.1016/j.jhep.2006.12.016
|
| 29 |
S. Arsov, R. Graaff, A. M. Morariu, W. van Oeveren, A. J. Smit, I. Busletic, L. Trajcevska, G. Selim, P. Dzekova, B. Stegmayr, A. Sikole, G. Rakhorst. Does hepatitis C increase the accumulation of advanced glycation end products in haemodialysis patients?. Nephrology Dialysis Transplantation 2010; 25(3): 885 doi: 10.1093/ndt/gfp564
|